Capital Fund Management (CFM)
JANX icon

Capital Fund Management (CFM)’s Janux Therapeutics JANX Stock Holding History

Capital Fund Management (CFM)’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Sell
101,972
-13,895
-12% -$201K 0.01% 1542
2026
Q1 		$1.61M Buy
+115,867
New +$1.59M 0.01% 1467
2025
Q3 		– Sell
-32,772
Closed -$757K – 2574
2025
Q2 		$757K Buy
+32,772
New +$864K ﹤0.01% 2094
2024
Q4 		– Sell
-14,888
Closed -$676K – 2146
2024
Q3 		$676K Buy
+14,888
New +$648K ﹤0.01% 1787

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Capital Fund Management (CFM)'s JANX Position: Q2 2026 in Review

Capital Fund Management (CFM) reduced its Janux Therapeutics (JANX) stake by 12% in Q2 2026, selling an estimated $201K and leaving 101,972 shares worth $1.57M. The position accounts for 0.01% of the portfolio, ranked #1542.

Capital Fund Management (CFM) first reported a position in JANX in Q3 2024 and has held it in 4 quarters since. The position peaked at $1.61M in Q1 2026. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Capital Fund Management (CFM) held 101,972 shares of Janux Therapeutics worth $1.57M as of Q2 2026.
  • Capital Fund Management (CFM) sold 13,895 Janux Therapeutics shares in Q2 2026, an estimated $201K.
  • Janux Therapeutics made up 0.01% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #1542 holding.
  • Capital Fund Management (CFM) first reported a position in Janux Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • Capital Fund Management (CFM)'s Janux Therapeutics position peaked at $1.61M in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.